325 related articles for article (PubMed ID: 1683191)
1. Controlled trial of H1 antagonists in the treatment of chronic idiopathic urticaria.
Sussman G; Jancelewicz Z
Ann Allergy; 1991 Oct; 67(4):433-9. PubMed ID: 1683191
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria.
Boggs PB; Ellis CN; Grossman J; Washburne WF; Gupta AK; Ball R; Shulan D
Ann Allergy; 1989 Dec; 63(6 Pt 2):616-20. PubMed ID: 2574555
[TBL] [Abstract][Full Text] [Related]
3. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis.
Monroe EW
Clin Ther; 1992; 14(1):17-21. PubMed ID: 1349509
[TBL] [Abstract][Full Text] [Related]
4. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria.
Salo OP; Harvey SG; Calthrop JG; Gibson JR
J Int Med Res; 1989; 17 Suppl 2():18B-21B. PubMed ID: 2569996
[TBL] [Abstract][Full Text] [Related]
5. Prolonged benefit in the treatment of chronic idiopathic urticaria with astemizole.
Honsinger RW; Thomsen RJ
Ann Allergy; 1990 Sep; 65(3):194-200. PubMed ID: 1976298
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria.
Brostoff J; Fitzharris P; Dunmore C; Theron M; Blondin P
Allergy; 1996 May; 51(5):320-5. PubMed ID: 8836336
[TBL] [Abstract][Full Text] [Related]
7. Combined H1 and H2 antihistamine therapy in chronic urticaria.
Monroe EW; Cohen SH; Kalbfleisch J; Schulz CI
Arch Dermatol; 1981 Jul; 117(7):404-7. PubMed ID: 6114712
[TBL] [Abstract][Full Text] [Related]
8. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria.
Monroe EW; Bernstein DI; Fox RW; Grabiec SV; Honsinger RW; Kalivas JT; Katz HI; Cuss F; Danzig MR; Garvin PR
Arzneimittelforschung; 1992 Sep; 42(9):1119-21. PubMed ID: 1445478
[TBL] [Abstract][Full Text] [Related]
9. Acrivastine versus hydroxyzine in the treatment of cholinergic urticaria. A placebo-controlled study.
Kobza Black A; Aboobaker J; Gibson JR; Harvey SG; Marks P
Acta Derm Venereol; 1988; 68(6):541-4. PubMed ID: 2467496
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients].
Paul E; Bödeker RH
Z Hautkr; 1985; 60 Suppl 1():50-5. PubMed ID: 2859714
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of the efficacy and tolerance of cetirizine verses astemizole in patients with allergic rhinitis].
Barthe P; Gómez JR; Suárez C; Ferro S; Figueres B
Acta Otorrinolaringol Esp; 1992; 43(3):183-7. PubMed ID: 1355345
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients.
Paul E; Bödeker RH
Ann Allergy; 1989 Apr; 62(4):318-20. PubMed ID: 2565098
[TBL] [Abstract][Full Text] [Related]
13. Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria.
Cainelli T; Seidenari S; Valsecchi R; Mosca M
Pharmatherapeutica; 1986; 4(10):679-86. PubMed ID: 2885854
[TBL] [Abstract][Full Text] [Related]
14. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists.
Lin RY; Curry A; Pesola GR; Knight RJ; Lee HS; Bakalchuk L; Tenenbaum C; Westfal RE
Ann Emerg Med; 2000 Nov; 36(5):462-8. PubMed ID: 11054200
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
Dubertret L; Murrieta Aguttes M; Tonet J
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
[TBL] [Abstract][Full Text] [Related]
16. Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial.
Pons-Guiraud A; Nekam K; Lahovsky J; Costa A; Piacentini A
Eur J Dermatol; 2006; 16(6):649-54. PubMed ID: 17229605
[TBL] [Abstract][Full Text] [Related]
17. Double-blind multicenter controlled clinical study comparing the efficacy of picumast dihydrochloride versus astemizole and placebo in patients with seasonal allergic rhinitis.
Franke W; Messinger D
Arzneimittelforschung; 1989 Oct; 39(10A):1360-3. PubMed ID: 2576364
[TBL] [Abstract][Full Text] [Related]
18. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of urticaria with the new H1 antihistaminic astemizole--with special reference to the time of onset of effect and maximum effect].
Kurz K
Z Hautkr; 1986 Nov; 61(22):1646-53. PubMed ID: 2880431
[TBL] [Abstract][Full Text] [Related]
20. Astemizole in combination with pseudoephedrine in the treatment of seasonal allergic rhinitis.
Simola M; Böss I; Holopainen E; Malmberg H; Ruoppi P; Seppä J; Siivonen L; Suonpää J; Piepponen T
Rhinology; 1996 Mar; 34(1):21-3. PubMed ID: 8739863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
